Toronto-Dominion Bank »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Toronto-Dominion Bank

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Toronto-Dominion Bank from 13F filings

Historical chart of Toronto-Dominion Bank investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Toronto-Dominion Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Toronto-Dominion Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $945k 1.1M 0.88
2025-06-30 $730k 1.0M 0.73
2025-03-31 $932k 1.0M 0.93
2024-12-31 $2.8M 2.5M 1.10
2024-06-30 $3.2M 2.5M 1.29
2023-12-31 $2.5M 2.5M 1.02
2023-09-30 $1.1M 1.0M 1.12

More positions owned by Toronto-Dominion Bank

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Cibc Cad (CM)
Tesla Motors (TSLA)
Amazon (AMZN)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Canadian Natural Resources (CNQ)
Spdr Gold Tr Gold Shs (GLD)
Bank Of Montreal Cadcom (BMO)
Meta Platforms Cl A (META)
Tc Energy Corp (TRP)
UnitedHealth (UNH)

View all positions for Toronto-Dominion Bank

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Balyasny Asset Management
Linden Advisors
Highbridge Capital Management
Oaktree Capital Management
D. E. Shaw & Co
DG Capital Management
Calamos Advisors
Davidson Kempner Capital Management
Agf Management
Readystate Asset Management
LMR Partners
State Street Corporation
Silver Point Capital
Man Group
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1